Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS

Arjun Kalvala1, Pierre Wallet2, Lu Yang3

  • 1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. akalvala@coh.org.

Insights

Mutant KRAS in non-small-cell lung cancer (NSCLC) causes immune-suppressive T cells. This study reveals a new mechanism for KRAS in T cell changes, offering a novel therapeutic target for NSCLC.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Mutant Kirsten rat sarcoma viral oncogene homolog (KRAS) drives cancer progression through uncontrolled cell proliferation and altered metabolism.
  • The role of KRAS in modulating the tumor microenvironment and immune cell function is not fully understood.

Purpose of the Study:

  • To investigate the cell-extrinsic effects of mutant KRAS on T cell phenotype and function.
  • To identify the underlying molecular mechanisms of KRAS-mediated T cell modulation in non-small-cell lung cancer (NSCLC).

Main Methods:

  • Incubation of CD4+ T cells with tumor-derived exosomes, patient sera, and xenograft models from mutant KRAS NSCLC.
  • Genetic manipulation of T cells with mutant KRAS cDNA.
  • Single-cell sequencing and mathematical modeling to elucidate the mechanism.

Main Results:

  • Exposure to mutant KRAS-associated factors induced a phenotypic conversion of CD4+ T cells to FOXP3+ regulatory T cell (Treg)-like, immune-suppressive cells.
  • Direct transfection of T cells with mutant KRAS cDNA replicated this phenotypic switch.
  • Single-cell sequencing identified the interferon pathway as the key mediator of this KRAS-induced T cell transformation.

Conclusions:

  • Mutant KRAS exerts a novel, cytokine-independent, cell-extrinsic influence on T cell phenotype, promoting immune suppression.
  • Targeting this KRAS-induced Treg-like cell population presents a promising therapeutic strategy for NSCLC.
  • The findings have broad implications for KRAS-mutated cancers due to KRAS's frequent mutation across various malignancies.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K